Re: prostrate cancer treatement-Reply

[RadiumProj@cs.com]

In a message dated 5/11/00 10:59:17 PM Eastern Daylight Time, Janzow1@aol.com 
writes:

> Date: 5/11/00 10:59:17 PM Eastern Daylight Time
>  From:    Janzow1@aol.com
>  Sender:  radsafe@romulus.ehs.uiuc.edu
>  Reply-to:    radsafe@romulus.ehs.uiuc.edu
>  To:  radsafe@romulus.ehs.uiuc.edu (Multiple recipients of list)
>  
>         A friend has recently been diagnosed with prostrate cancer.  
>  Recommended trearment is via implanted radioactive seeds.
>        He is curious as to the isotope involved, half-life, precautions he 
>  should take after release from the hospital with respect to  exposure to 
>  others, etc.
>         Can anyone supply comments, references, or other info?
=====
Information on the use of Pd-103, one of the isotopes used in seed form to 
treat prostate cancer can be found at the website for Theragenics of Buford, 
GA. Pd-103 is regarding as having some significant advantages over seeds 
containing other isotopes since Pd-103 is a short half life, low energy beta 
emitter that delivers essentially no dose to structures outside the prostate 
or tissue in which the seeds are placed.  For info on Pd-103 see:

http://www.theragenics.com/

Good luck.
Stewart Farber, MS Public Health
email: radiumproj@cs.com
************************************************************************
The RADSAFE Frequently Asked Questions list, archives and subscription
information can be accessed at http://www.ehs.uiuc.edu/~rad/radsafe.html